The synthetic cathinones are powerful psychostimulants that have been associated with impairment, intoxication and fatal overdose. Forensic laboratories must be able to identify these new drugs as part of antemortem and postmortem toxicology investigations. Preliminary reports have indicated that some of the synthetic cathinones are unstable in biological matrices. It is important to understand drug stability in biological evidence so that analytical findings can be interpreted appropriately. The objective of this study was to systematically evaluate the concentration, temperature and analyte-dependent stability of synthetic cathinones in preserved blood using liquid-chromatography/ quadrupole-time of flight-mass spectrometry (LC/Q-TOF-MS). Cathinone stability was investigated at frozen, refrigerated, ambient and elevated temperature (−20°C, 4°C, 20°C and 32°C). Although no concentration dependent differences in stability were observed, cathinone stability was highly temperature and analyte-dependent. Substituents on the aromatic ring and nitrogen profoundly influenced stability. Tertiary amines (pyrrolidinyl analogs) were significantly more stable than their N-alkylated (secondary amine) counterparts. Furthermore, the methylenedioxy (MD) group also exerted a significant stabilizing effect, for both secondary and tertiary amines. The unsubstituted and ring-substituted secondary amines were the least stable, most notably 3-fluoromethcathinone (3-FMC). Under some conditions, significant losses were observed within hours of storage. Half-lives ranged from a little as 8 h (3-FMC) to 21 days (3,4-methylenedioxy-α-pyrrolidinobutiophenone, MDPBP) at elevated temperature (32°C). In contrast, half-lives ranged from 0.4 to >10 months when refrigerated and demonstrated even greater stability when frozen. Biological evidence may be subjected to a variety of environmental conditions prior to, and during transport to the laboratory. These findings highlight the need to consider the potential for both temperature and analyte-dependent differences. Due to the inherent instability of certain drugs within the class, quantitative drug findings in toxicological investigations must be interpreted with caution, and within the context of specimen storage and integrity.
Introduction
The synthetic cathinones are powerful amphetamine-like psychostimulants that have increased in popularity in the USA since 2009 (1) . According to the Drug Enforcement Administration, cathinones were reported in 48 of the 50 states in 2015, with the highest number of reports occurring in the South and Midwest regions. In 2010, the most common cathinones in the USA were mephedrone, methylenedioxypyrovalerone (MDPV) and methylone (2) . From 2013 to 2015 however, methylone, α-pyrrolidinopentiophenone (α-PVP) and ethylone accounted for 91% of all reports. In addition to increased drug seizures, illicit drug manufacturers produce new cathinones as part of their ongoing attempt to circumvent drug laws and evade judicial consequences. This is evidenced by the fact that the number of synthetic cathinones encountered in the National Forensic Laboratory Information System increased from 5 in 2009 to 35 in 2015. The sought-after effects of these drugs include increased energy, empathy, openness and libido. However, cardiac, psychiatric and neurological effects are common among users that require medical intervention. Over the past decade, the federal government has taken numerous steps to ban specific synthetic cathinones and the majority of states have enacted legislation, often in the form of general class bans, in an effort to curb their appeal.
These compounds present a challenge to the forensic toxicology community due to the number of structurally related analogs and regioisomers that currently exist. The cathinones are β-keto amphetamines (2-aminopropiophenones) that can be categorized into Nalkylamines (secondary amines) and pyrrolidines (tertiary amines). The chemical properties of these arylaminoketones are dominated by two functional groups: the ketone and the amine. The cathinones are either ring-substituted (R 1 and R 2 ), formed by the variation of the α-carbon substituent (R 3 ), or N-alkylated (R 4 and R 5 ) (Figure 1 ). At the inception of this study, a total of 22 synthetic cathinones were commercially available and the individual structures of these compounds are shown in Figure 2 .
Drug stability must be carefully considered when interpreting toxicological results (3). Pre-analytical conditions, including specimen transport, storage and handling may cause the drug concentration to change. The stability and intrinsic chemical properties of many illicit and pharmaceutical drugs are widely known and understood, but this information is relatively limited for the synthetic cathinones. An increased understanding of cathinone stability is needed due to the prevalence of these drugs in criminal and death investigations (4) (5) (6) (7) (8) (9) . Forensic toxicology laboratories go to considerable lengths to ensure the precision and accuracy of their quantitative results. However, in order to reliably interpret those results, drug stability and pre-analytical changes in drug concentration should be carefully considered.
While the proliferation of cathinone compounds over the past decade has renewed interest in the stability of synthetic cathinones, the instability of cathinone (its natural precursor) has been understood for decades. Cathinone was first identified in the 1970s as the principle pharmacologically active compound in "khat". Although its degradation product (cathine) had been identified years earlier, the delay in the identification of cathinone was largely due to its instability in the plant material (10) (11) (12) (13) . Cathinone was also reported to be unstable in basic conditions (11, 14) . More recently, Tsujikawa, et al. investigated the stability of five synthetic cathinones in aqueous solutions over a range of pH. They concluded that drug stability increased with decreasing pH and that the rate of decomposition was likely dependent on the chemical structure (14) . Cathinone instability was also observed during gas chromatography-mass spectrometry (GC-MS) analysis. Under some conditions cathinones can thermally degrade, resulting in the formation of oxidative breakdown products (15) (16) (17) .
There are a relatively small number of studies that have addressed synthetic cathinone stability in blood or plasma. Morad et al. was the first to report that cathinone was unstable in plasma in 1989 (18) . More recently, issues associated with quantitative reproducibility and stability of the newer designer cathinones have emerged. Marinetti and Antonides described that the lack of reproducibility of methylone and methedrone in toxicological samples in a series of published case reports (19) . Soon thereafter, Johnson and Botch-Jones investigated the stability of MDPV and mephedrone at 1,000 ng/mL in blood, plasma and urine over 14 days of storage (20) . Mephedrone was considerably less stable than MDPV, demonstrating complete loss (100%) after 7 days of storage at room temperature in blood. Both drugs were stable under frozen storage conditions for the entire 2-week period. Based on the considerable difference between mephedrone and MDPV, the authors emphasized the need for additional research and the need to consider chemical instability when interpreting results.
Li et al. investigated the stability of 11 synthetic cathinones in equine plasma over various time intervals. Samples were stored at 25°C for 24 h, 4°C for 7 days, −20°C for 4 weeks and −70°C for 24 weeks (6 months). The authors concluded that the 11 cathinones were stable for 30 days at −20°C, and 6 months in −70°C. Most were stable at room temperature for 24 h, with the exception of 4-fluoromethcathinone (4-FMC), 3-FMC and 3-methyoxymethcathinone (21). Soh and Elliott also described the stability of 4-methylethcathinone (4-MEC) in blood and plasma at ambient temperature (22) . 4-MEC, originally fortified at 2,000 ng/mL was undetectable within 14 days, although plasma was reported to have greater stability. Busardò investigated the stability of mephedrone in antemortem and postmortem blood over 6 months, concluding that preserved blood should be stored at −20°C to prevent significant loss (23) . Mephedrone was undetectable after 30 days at 20°C, 90 days at 4°C and stable at −20°C for the duration of the 6-month study.
In this report, we describe the systematic evaluation of 22 synthetic cathinones in preserved blood to evaluate concentration, analyte and temperature dependent differences in stability. Over a period of 6 months, stability was evaluated at four temperatures, selected to represent frozen (−20°C) and refrigerated (4°C) longand short-term storage temperatures at the laboratory; exposure to ambient (20°C) or room temperature during routine processing and handling; and finally, potential exposure to elevated temperatures, which might be experienced during shipping and transport to the laboratory (32°C).
Materials and Methods

Chemicals and reagents
Methcathinone, 3-FMC, 4-FMC (flephedrone), methylone, ethcathinone, ethylone, methedrone, buphedrone, butylone, mephedrone, eutylone, 4-MEC, MDPBP, pentedrone, pentylone, 3,4-dimethylmethcathinone (3,4-DMMC), α-PVP, 4-ethylmethcathinone (4-EMC), 4-methyl-α-pyrrolidinobutiophenone (MPBP), MDPV, pyrovalerone, and naphyrone were purchased from Cerilliant Corporation (Round Rock, TX, USA) in 1.0 mg/mL methanolic solutions. Internal standards methylone-D3, ethylone-D5, buytlone-D3, mephedrone-D3, eutylone-D5, pentylone-D3, alpha-PVP-D8, MDPV-D8 and naphyrone-D5 were also purchased from Cerilliant Corporation in 0.1 mg/mL methanolic solutions. Bovine blood containing 1% (w/v) sodium fluoride and 0.2% (w/v) potassium oxalate was purchased from Quad Five (Ryegate, Montana, USA). Commercial evacuated glass tubes without additional preservative (BD Vacutainer™ red-top tubes, 10 mL, 16 × 100 mm) were purchased from VWR (Radnor, PA, USA).
Dichloromethane, isopropyl alcohol and glacial acetic acid were purchased from Mallinckrodt Chemicals (St. Louis, MO, USA). LC-MS grade methanol, concentrated hydrochloric acid, LC-MS grade acetonitrile and dibasic sodium phosphate were purchased from J.T. Baker (Center Valley, MA, USA). Optima ® Hexane and HPLC grade ethyl acetate were purchased from Fisher Scientific (Fair Lawn, NJ, USA). Formic acid (>99%) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and monobasic sodium phosphate was purchased from VWR (Radnor, PA, USA). Deionized water was purified in-house using a Millipore Direct-Q ® UV Water Purification system (Billerica, MA, USA). PolyChrom ClinII 3 cc (35 mg) solid phase extraction (SPE) columns were purchased from SPEware (Baldwin Park, CA, USA). Phosphate buffer (pH 6, 0.1 M) was prepared from 0.1 M solutions of mono and dibasic sodium phosphate, and acidic methanol consisted of concentrated hydrochloric acid diluted in methanol (2%, v/v).
The elution solvent (prepared daily) consisted of 2% concentrated ammonium hydroxide in 95:5 dichloromethane/isopropyl alcohol (v/v).
Instrumental analysis
An Agilent Technologies 6530 LC-Q/TOF-MS (Santa Clara, CA, USA) equipped with an Agilent 1290 Infinity autosampler and a Series 1200 LC system was used for analysis. The LC system was equipped with an Agilent Poroshell 120 EC-C18 column (2.1 × 100 mm, 2.7 μm particle size) and a Poroshell 120 EC-C18 guard column (2.1 × 5 mm, 2.7 μm particle size) located in a thermostatically controlled column compartment (35°C). Nitrogen was generated using a Genius 3040 Nitrogen Generator (Peak Scientific, Billerica, MA, USA). SPE was performed using a JT Baker vacuum manifold and extracts were evaporated to dryness under nitrogen using a TurboVap LV ® concentration workstation (Caliper Life Sciences, Hopkinton, MA, USA). Mobile Phase A consisted of 0.1% formic acid in deionized water and Mobile Phase B consisted of 0.1% formic acid in acetonitrile. The LC-Q/TOF procedure used for the quantification of cathinones in blood was previously published and validated in accordance with generally accepted guidelines (24, 25) .
Preparation and sampling of blood
Preserved drug-free blood (1 L, pH 7.35-7.45) was fortified with 20 synthetic cathinones to achieve a final concentration of 100 and 1,000 ng/mL. Blood was immediately aliquoted into glass Vacutainer™ tubes and stored at the appropriate temperature for the duration of the study (−20°C, 4°C, 20°C and 32°C). The experimental design is summarized in Figure 3 . Aliquots at each concentration were immediately removed and analyzed to establish T 0 (0% loss). At each sampling interval a single Vacutainer™ tube was removed from each temperature and aliquots (n = 2) were removed and analyzed using the validated procedure. After aliquots were removed, Vacutainer™ tubes were returned to the appropriate storage temperature. Sampling frequency was variable throughout the study. During the initial 48 h, quantitative analysis was performed every 2-6 h. Sampling remained frequent (4 assays/week) throughout the initial month, decreasing thereafter. Calibrators (10, 25, 100, 250, 350 and 500 ng/mL) and controls (0 and 100 ng/mL) were included in each run. Where appropriate, analysis of variance (ANOVA) was used to determine statistical significance (α = 0.05).
The drug was considered unstable when the concentration decreased by more than 20% of the original (T 0 ) concentration.
Isolation of cathinones from blood
Internal standard solution (0.5 μg/mL) was added to 2.0 mL blood to achieve a final concentration of 25 ng/mL. A protein precipitation was performed using 4 mL of cold acetonitrile. The samples were then centrifuged at 4,000 RPM for 5 minutes. The organic layer was decanted and diluted with 6 mL of pH six phosphate buffer (0.1 M) and briefly vortexed. Samples were transferred to PolyChrom ClinII SPE columns and allowed to flow through under gravity. Columns were rinsed with 1 mL deionized water followed by 1 mL of 1 M acetic acid. Columns were dried under full vacuum for 5 min and washed successively, with 1 mL of hexane, ethyl acetate, methanol, and dichloromethane. Synthetic cathinones were eluted using two 0.5 mL aliquots of elution solvent (2% conc. ammonium hydroxide in 95:5 dichloromethane: isopropyl alcohol). Acidic methanol (30 μL) was added to each extract prior to evaporation under nitrogen at 50°C. Extracts were reconstituted in 25 μL of 50:50 mixture of Mobile Phase A:B and 1 μL was injected onto the LC-Q/TOF-MS for analysis. Extraction efficiencies using this previously published procedure were 81-93% and limits of quantitation (LOQ) were 1-5 ng/mL (24) .
Data analysis
One-way ANOVA was used to statistically evaluate concentration, temperature, and analyte dependence. Concentration dependence was assessed by comparing the percentage of drug remaining (% target) at 100 ng/mL and 1,000 ng/mL to normalize the data. Absolute concentrations (ng/mL) were used to evaluate temperature and analyte dependence. To properly evaluate analyte dependence, ANOVA was used to examine variances within a population prior to comparisons between populations to ensure show that differences within a group were not significant (F < F CV or F-crit). No significance testing was performed when drug concentrations were within 20% of the initial (T 0 ) concentration for the entire duration of the study. Half-lives (T 1/2 ) for each drug were determined by estimating rate constants (k), assuming first order decay, based upon duplicate measurements at each time interval (T 1/2 = Ln2/k). Rate plots were only generated if a significant decrease in concentration (>20%) was evident over three consecutive measurements. Due to the large number of drugs, graphical representations of the data were color-coded to facilitate interpretation. Cathinones (2°amines) without aromatic substituents (R 1 and R 2 = H) were identified in green, 2°amines with aromatic substituents (R 1 or R 2 ≠ H) were yellow, cathinones with MD groups were indicated with a magenta line (for both 2°a nd 3°amines), and 3°amines (pyrrolidine-type) cathinones were shown in purple.
Results and Discussion
Half-life estimation
To estimate half-lives, rate plots were generated and are summarized in Supplementary Figure S1 . In whole blood, half-lives were estimated for all drugs at elevated and ambient temperatures. In contrast, with the exception of 3-FMC, all drugs were stable for the entire 6-month period when frozen. Cathinone half-lives in blood ranged from 8 h (3-FMC) to 21 days (MDPBP) at elevated (32°C) temperature and 22 h to almost 3 months at ambient (20°C) temperature. At refrigerated and frozen temperatures, synthetic cathinones were considerably more stable and half-lives were measured for some but not all of the drugs (Table I) . These findings highlight the significant temperature and analyte-dependent differences in stability, which are discussed in more detail below.
Concentration dependence
No concentration dependent differences in stability were observed for any of the drugs. Figure 4 depicts representative stability data for refrigerated blood at both concentrations tested (100 and 1,000 ng/mL). One-way ANOVA analysis confirmed lack of significance for unstable drugs (methcathinone, 32°C, F(1, 58) = 0.004, P = 0.95) and stable drugs (pyrovalerone, 32°C, F(1, 54) = 0.392, P = 0.534) alike. Due to the absence of concentration dependent stability for any of the cathinones, all subsequent statistical evaluations of temperature and analyte dependence were routinely undertaken at 1,000 ng/mL unless otherwise stated.
Analyte dependence
In order to evaluate the significance of analyte dependence, ANOVA was used to examine the variances within and between populations. For example, before determining the significance of the MD group, it was necessary to show that differences within the group were not significant. Due to notable differences in stability for some of the fluorinated cathinones, it was necessary to exclude them for some of the comparisons. Among the secondary amines, there were no significant differences in stability between unsubstituted and ring-substituted cathinones at elevated and ambient temperatures in blood. This was attributed to their very rapid degradation under these conditions. No significant differences were observed in refrigerated or frozen blood when 3-FMC and 4-FMC were excluded. Addition of the MD group had a significant stabilizing effect. The MD-substituted secondary amines (ethylone, butylone, pentylone, methylone, eutylone) were considerably more stable than their unsubstituted counterparts (methcathinone, ethcathinone, buphedrone, pentedrone). The stabilizing effect of the MD group was also evident for the tertiary amines (pyrrolidines). MD-substituted pyrrolidines (MDPBP and MDPV) were generally observed to be more stable that their non-MD-substituted counterparts (α-PVP, MPBP, pyrovalerone and naphyrone), although in all but a few instances, the differences were not statistically significant. Comparisons between these groups were not always possible due to within group variability among the pyrrolidinyl analogs, notably naphyrone (the least stable of the tertiary amines). The stabilizing effect of the MD group was evident throughout, most notably between the MD-substituted tertiary amines and the unsubstituted secondary amines (F(5, 125) = 4.7, P < 0.0001) and the substituted secondary amines (F(8, 252) = 3.1, P = 0.002) in refrigerated blood.
The nitrogen substituent exerted an even greater stabilizing influence. Tertiary amines were consistently more stable than their secondary amine counterparts. This stabilizing effect was even evident when comparing the most stable MD-substituted secondary amines with their pyrrolidinyl counterparts. Additionally, MD-substituted tertiary amines were more stable than MD-substituted secondary amines at refrigerated temperature (F(6, 165) = 2.9, P < 0.01).
Cathinone stability was highly analyte-dependent. Pyrrolidinyltype cathinones with tertiary amines were notably more stable than their secondary amine counterparts. The inability of the tertiary amines to undergo oxidative deamination is a likely explanation. Although significant differences between unsubstituted and ringsubstituted secondary amines were not observed, substitution with a MD group had a notable stabilizing effect for all drugs. Among the 20 drugs tested, MD-substituted pyrrolidinyl cathinones were the most stable (i.e., MDPBP, MDPV), followed by tertiary amines (α-PVP, MPBP, pyrovalerone, naphyrone) and MD-substituted secondary amines (ethylone, butylone, pentylone, methylone, eutylone). Unsubstituted (methcathinone, ethcathinone, buphedrone, pentedrone) and ring-substituted cathinones (mephedrone, 4-MEC, 4-EMC, methedrone, 3,4-DMMC, 3-FMC, 4-FMC) were considerably less stable, with 3-FMC exhibiting the greatest instability.
Temperature dependence
Cathinone stability was also highly temperature dependent ( Figure 5 ). Temperature dependent differences were significant (P < 0.001) for all 22 cathinones at both 100 and 1,000 ng/mL. For the most unstable drug (3-FMC) half-lives ranged from 8 h at elevated temperature to almost 3 months when frozen. These results highlight how low storage temperatures can significantly reduce degradation, even for the most unstable cathinone species. The dramatic influence of temperature on half-life (Table I) is shown graphically in Supplementary Figure S2 . Table II summarizes the number of days to significant (20%) or complete (100%) loss of drug in blood originally fortified at 100 ng/mL. These data not only highlights the importance of storage temperature on cathinone stability, but also the analyte-dependent variables discussed earlier. With the exception of 3-FMC, all of the cathinones were relatively stable or exhibited only moderate losses (<40%) in blood after 30 days of refrigerated storage and significant losses were not observed until 2.5 months of frozen storage. At elevated temperature (32°C), significant losses were observed for unsubstituted and ring-substituted cathinones within 24 h, compared with days or weeks for the pyrrolidines. Unless specifically packaged to protected from heat, it is not uncommon for specimens to be exposed to elevated temperatures during shipping and transport to the laboratory, particularly during summer months. At ambient temperature (20°C), all 20 were unstable by Day 27, with the exception of MDPBP and MDPV (MD-substituted tertiary amines), which were unstable by Day 55. In contrast, the secondary amines with and without ring substituents experienced significant losses (>20%) within 1-8 days. The ranges presented in Table II by chemical structure summarize days until significant (>20%) loss and 100% loss in blood (originally fortified at 100 ng/mL). These data also highlights that despite significant changes in concentration that might take place for some drugs under certain conditions, all the cathinones included in the study were detectable in blood for extended periods of time when refrigerated or frozen. It should be noted however that actual detection times are influenced by many factors, including dose of the drug (initial concentration) and the sensitivity of the assay.
Conclusions
Cathinone use is an ongoing drug problem, evidenced by increased drug seizures, adverse effects and fatalities. Cathinone stability was investigated to determine concentration, temperature and analyte dependence. Although no concentration dependence was observed, cathinone stability was greatly influenced by temperature and analyte-dependent variables. Figure 6 summarizes overall analytedependent differences in stability among the 22 cathinones evaluated. Nitrogen substituents and MD ring-substitutions had the greatest impact. With the exception of 3-FMC, ring substituents had limited influence on stability among the secondary amines; differences in stability between ring-substituted secondary amines were of sufficient magnitude to preclude any statistically significant difference between ring-substituted and unsubstituted cathinones.
Although a highly systematic approach was taken in this study to address concentration, analyte and temperature dependent effects, the Johnson and Botch-Jones' study of MDPV and mephedrone noted considerable differences in stability between the tertiary and secondary amine and also recommended frozen storage to minimize losses (20) . The study of mephedrone in antemortem and postmortem blood reported by Busardò concluded that mephedrone was undetectable after 30 days at 20°C (23) . These results are in close agreement with our results, which showed that mephedrone was undetectable by 27 days. Drug instability and the magnitude of the loss was heavily influenced by temperature and chemical characteristics. Therefore, concentrations at the time of testing may not always reflect those at the time of interest e.g., time of death or time of driving. Although drugs may still be detectable, significant losses are possible. Given that biological evidence is sometimes exposed to unfavorable conditions in both postmortem and antemortem toxicology investigations during routine shipping and transport to the laboratory, toxicological findings should be interpreted cautiously and within the full context of evidence disposition. These finding are of value in forensic toxicology investigations involving these cathinones. However, a greater understanding of analyte-dependent variables (specifically functional groups that have stabilizing effects) has a much broader impact, because it may allow us predict the stability of future synthetic cathinones, as these designer drugs continue to evolve.
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